Labor and Delivery Complication clinical trials at UCSF

1 research study open to eligible people

Labor and delivery complications are issues that arise during childbirth. UCSF is conducting a study to check if azithromycin can prevent infections in cesarean deliveries. The trial includes 8,000 participants for thorough examination of its effectiveness.

Showing trials for

  • Azithromycin Prophylaxis for PRElabor CEsarean DElivery Trial

    open to eligible females

    This is a phase-III multi-center double-blind randomized controlled trial of 8,000 individuals undergoing a scheduled or prelabor cesarean delivery who are randomized to either adjunctive azithromycin prophylaxis or to placebo. Both groups also will receive standard of care preoperative antibiotics (excluding azithromycin). The primary endpoint is a maternal infection composite defined as any one of the following up to 6 weeks postpartum: endometritis, wound infection, abscess, septic thrombosis, sepsis, pneumonia, pyelonephritis and breast infection.

    San Francisco, California and other locations

Our lead scientists for Labor and Delivery Complication research studies include .

Last updated: